PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1616679
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1616679
U.S. Dialysis Market exhibited USD 28.8 billion in 2023 and will expand to a 5.5% CAGR from 2024 to 2032, spurred by the rising number of end-stage renal disease (ESRD) patients and the increasing incidence of diabetes. As diabetes becomes more prevalent, it heightens the risk of developing kidney-related complications, leading to a greater demand for dialysis services. Also, the aging population contributes to the growing prevalence of ESRD, further stressing healthcare systems. This surge in patient numbers necessitates advancements in dialysis technology and treatment options, ultimately expanding the market and improving patient outcomes.
The U.S. dialysis industry is fragmented based on type, product & services, end-use, and region. The hemodialysis segment upheld USD 25.4 billion in 2023 due to its widespread adoption as a primary treatment for end-stage renal disease (ESRD). Hemodialysis offers effective filtration of blood, making it a preferred choice for many patients requiring regular treatment. The availability of advanced hemodialysis machines and improved access to outpatient facilities further enhance its appeal.
Besides, as awareness of kidney health increases and more patients are diagnosed with ESRD, the demand for hemodialysis services is likely to continue growing, solidifying its market dominance. The service segment garnered 78.3% share in 2023, driven by the increasing demand for comprehensive care and support for patients with end-stage renal disease (ESRD). This segment encompasses various services, including dialysis treatment, patient education, and care coordination, which are essential for ensuring optimal patient outcomes. As healthcare providers focus on enhancing the patient experience and improving accessibility to dialysis services, the emphasis on service-oriented solutions will grow.
Market Scope | |
---|---|
Start Year | 2023 |
Forecast Year | 2024-2032 |
Start Value | $28.8 Billion |
Forecast Value | $45.5 Billion |
CAGR | 5.5% |
This trend positions the service segment as a vital component of the overall dialysis market. The South Atlantic dialysis industry secured USD 6.5 billion in 2023 and will grow at a 5.1% CAGR through 2032, driven by a growing population and increasing prevalence of chronic kidney diseases. The area has a high concentration of healthcare facilities specializing in renal care, making dialysis services more accessible to patients. Moreover, rising awareness of kidney health and advancements in dialysis technology are further fueling demand.As the region continues to prioritize healthcare infrastructure and patient support, the South Atlantic will stand as a vital contributor to the overall dialysis market.